惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

The GitHub Blog
The GitHub Blog
M
MIT News - Artificial intelligence
Engineering at Meta
Engineering at Meta
云风的 BLOG
云风的 BLOG
博
博客园 - 叶小钗
Jina AI
Jina AI
Last Week in AI
Last Week in AI
The Cloudflare Blog
博
博客园 - 【当耐特】
Stack Overflow Blog
Stack Overflow Blog
Cyber Security Advisories - MS-ISAC
Cyber Security Advisories - MS-ISAC
WordPress大学
WordPress大学
博
博客园_首页
I
InfoQ
G
Google Developers Blog
Martin Fowler
Martin Fowler
Recent Announcements
Recent Announcements
H
Help Net Security
U
Unit 42
Blog — PlanetScale
Blog — PlanetScale
阮一峰的网络日志
阮一峰的网络日志
P
Proofpoint News Feed
IT之家
IT之家
Microsoft Security Blog
Microsoft Security Blog

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
abrdn Life Sciences Investors Q1 2026 Commentary
2026-05-20 · via All Articles on Seeking Alpha

Summary

  • The equity portion of the Abrdn Life Sciences Investors Fund rose (gross of fees) but underperformed its benchmark, the NASDAQ Biotechnology Index.
  • U.S. equities were relatively resilient earlier in the quarter but ended it sharply lower.
  • The conflict in the Middle East led to airspace closures and the blockage of most oil shipments via the Strait of Hormuz.
  • During the quarter, the US Federal Reserve (Fed) kept the federal funds target range at 3.50%–3.75%.
A professional doctor in a white medical uniform working with a team of specialists including doctors. Research and development of nursing assistants in medical technology service laboratories Advise patients to solve public health, medical business probl

Sakorn Sukkasemsakorn/iStock via Getty Images

Fund performance

The equity portion of the Fund rose (gross of fees) but underperformed its benchmark, the NASDAQ Biotechnology Index. 1

Fulcrum Therapeutics (FULC) detracted after disappointing 'phase 3' results for its lead program in

191 Followers

此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。